Clover Health Investments — Ethics Grade C-

Clover Health Investments receives an overall ethics grade of C- (44/100) on CancelCo's corporate accountability database. Sector: Consumer Goods. Market cap: Mid Cap.

Category scores

• labor: 60
• privacy: 50
• consumer: 35
• environment: 70
• humanRights: 65

Documented incidents (3)

• Undisclosed SEC Investigation (high, 2021) — Accused by Hindenburg Research of failing to disclose an active DOJ investigation into its business practices to investors prior to going public via SPAC.
• Medicare Upcoding Allegations (medium, 2022) — Scrutinized for suspicious diagnosis codes that inflated Medicare payments, a practice known as 'upcoding' that costs taxpayers billions.
• Deceptive Medicare Advantage Ads (medium, 2023) — Faced criticism for marketing practices that allegedly misled seniors about the coverage and availability of specialized medical networks.

Documented good deeds

• Open Data for Care Coordination — Shared outcomes data from its Clover Assistant tool to help improve general physician awareness of chronic disease management.

Ethical alternatives

• Oscar Health — Higher transparency scores and better consumer satisfaction ratings with digital interfaces.